share_log

英特集团(000411.SZ):跨境电商业务以英特国际药业为主体,目前处于起步发展阶段

Intel Group (000411.SZ): The cross-border e-commerce business is dominated by Inter International Pharmaceuticals and is currently in the initial development stage

Gelonghui Finance ·  Dec 27, 2023 02:23

Gelonghui, December 27丨An investor asked Intel Group (000411.SZ) on the investor interactive platform, “Please ask if the development status of your cross-border e-commerce business will be beneficial to the company's development.” The company replied that the company's cross-border e-commerce business is mainly based on Intex International Pharmaceuticals. Currently, it is in its infancy and sales are not large.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment